With a PhD in Epidemiology and a MS in Biostatistics, Dr. Aggarwal brings over 15 years of experience in industry including Amgen, Regeneron, and IQVIA, and academia. Specializing in real-world evidence generation strategy, she excels in identifying fit-for-purpose data and designing studies that cater to the needs of various stakeholders. Her expertise spans the entire spectrum of real-world evidence generation, from early-phase and pipeline assets to post-authorization activities.
At Landmark, Dr. Aggarwal leads a team of skilled epidemiologists and programmers, and remains dedicated to driving evidence-based decision-making across the healthcare industry, guiding strategic initiatives that aim to enhance patient care and treatment outcomes. Her passion for leveraging data to inform evidence-based practice and policy-making underscores her commitment to advancing the field of epidemiology and biostatistics.
